BUGS&DRUGS

BUGS&DRUGS By www.FreePharmacyJobs.com

Following the Pharmacy market and the products and services which drive it forward.

Web

Images

BUGS&DRUGS >> PHARMACEUTICAL INDUSTRY

November 27, 2009

members login here

Focus Channels

  Biological sciences
  Biotech
  Cancer
  Genetics
  Healthcare
  Medical
  Pharmaceutical Industry
  Public health

Participate

Build a News Circle

Receive News Briefings

Add this Circle to favorites

Share this News Circle

Subscribe to this News Circle

Useful Links

Pharmacy Jobs

>>	PHARMACEUTICAL INDUSTRY

North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug

Reuters - 3 Hours ago

DURHAM, N.C., Nov. 27 /PRNewswire/ -- Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble

North Carolina-based Cnanoz Unveils NanoPure to Government Leaders in Hyderabad, Carolina Newswire

North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, E Releases

all 2 news articles >> Add Comment

Idera Pharmaceuticals and Merck extend research collaboration - Z...

Zibb - 3 Hours ago

Companies: Idera Pharmaceuticals Inc (IDRA), Merck & Co., Inc. (MRK) Idera Pharmaceuticals, a biotechnology company, has reported that Merck & Co, through an affiliate, has extended its research collaboration

Idera Pharmaceuticals and Merck extend research collaboration TradingMarkets

all 1 news articles >> Add Comment

Incyte signs collaboration and licensing agreement with Novartis ...

Zibb - 7 Hours ago

Company: Novartis AG (NVS) Incyte, a US-based drug discovery and development company, has entered into a collaboration and licensing agreement with Swiss pharmaceutical group Novartis for two of its investigational

Incyte signs collaboration and licensing agreement with Novartis Individual.com

Incyte enters collaboration & license pact with Novartis for 2 haematology-oncology PharmaBiz

all 2 news articles >> Add Comment

Merck to expand R&D presence in China

Individual.com - 2 Hours ago

Merck KGaA has announced plans to strengthen its global R&D capabilities of its Merck Serono division by establishing a global R&D center in Beijing, China. Merck is planning to invest more than E150

Merck to expand R&D presence in China - Zibb.com Zibb

all 1 news articles >> Add Comment

(Tentative) Q3 2009 HEI, Inc. Earnings Release - ESTIMATED

Reuters - 18 Hours ago

HEI, Inc. (HEI) operates two business segments that provide a suite of services from design and development, testing to transitional manufacturing and service contract manufacturing. The CompanyÃ¢â?¬â?¢s

(Tentative) Q3 2009 MDI, Inc. Earnings Release - ESTIMATED Reuters

(Tentative) Q3 2008 VIOQUEST PHARMACEUTICALS INC Earnings Release - ESTIMATED Reuters

all 2 news articles >> Add Comment

Natco Pharma plans to fight Teva's citizen petition for Glatiramer Acetate

PharmaBiz - 6 Hours ago

Natco Pharma, a Rs 400 crore Hyderabad-based pharma company, is planning to suitably respond to Teva Pharma's Citizen Petition with the US FDA regarding Glatiramer Acetate product. Teva had alleged, that

INDIA'S NATCO PHARMA FLAYS TEVA FOR FILING CITIZEN PETITION Individual.com

NATCO terms Teva's Citizen Petition a ploy to delay Generic Competition Equity Bulls

all 3 news articles >> Add Comment

4-Star Stocks Poised to Pop: Wal-Mart

Motley Fool - 3 Hours ago

Based on the aggregated intelligence of 145,000-plus investors participating in , the Fool's free investing community, retail behemoth Wal-Mart Stores (NYSE: WMT) With that in mind, let's take a closer

5-Star Stocks Poised to Pop: Exelon Motley Fool via MSN Money

4-Star Stocks Poised to Pop: Sequenom The Money Times

all 6 news articles >> Add Comment

Verdun signs letter of intent to attend DePaul

Morris Daily Herald - 3 Hours ago

Last spring, Kirsten Verdun helped take the Coal City Lady Coalers to East Peoria, where they finished third in the IHSA Class 2A Softball State Tournament. Beginning with the 2010-11 school year, Verdun

NS Athletes Sign Letters of Intent Roslyn News

Roslyn Senior Signs Letter of Intent Roslyn News

all 4 news articles >> Add Comment

Tellabs Down 11.6% Since SmarTrend's Sell Recommendation

TradingMarkets - 3 Hours ago

Disclaimer: The Connors Group, Inc. ('Company') is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or

Array Biopharma Down 32.4% Since SmarTrend's Sell Recommendation Individual.com

Books-A-Million Down 31.9% Since SmarTrend's Sell Recommendation Individual.com

all 113 news articles >> Add Comment

Ex-RBS chairman joins pharma group's aristocratic board

Financial News Online - 6 Hours ago

Former chairman , on whose watch the bank was forced into a government bailout, has returned to his pharmaceuticals roots as a director of a Brussels-listed firm whose board includes a countess and a

Add Comment

Sun Pharma's ADHD Generic Tentatively Approved in US

Pharmaceutical Technology - 7 Hours ago

India's Sun Pharma has been awarded tentative approval from the US Food and Drug Administration for its generic Strattera capsules to treat attention deficit hyperactivity disorder (ADHD). Sun Pharma's

Sun Pharma announces USFDA OK for Generic Strattera capsules Financial Express

Sun Pharma gets FDA permit for generic Strattera capsules Bio Spectrum Asia

all 6 news articles >> Add Comment

Clearwire Communications raises $1,057 million through private placement

TMC Net - 16 Hours ago

(Datamonitor Financial Deals Tracker via COMTEX) -- Clearwire Communications, LLC, a US-based provider of internet services, has raised $1,057 million out of a planned $1,564 million private stock offering.

Jazz Pharmaceuticals raises $120 million through private placement Individual.com

Poniard Pharmaceuticals raises $7.45 million in secondary offering Individual.com

all 14 news articles >> Add Comment

Sanofi Aventis : Sanofi-aventis confirme son...

Investegate - 5 Hours ago

PR Newswire/Les Echos/ CommuniquÃ© de presse Sanofi-aventis Sanofi-aventis confirme son intention de renforcer sa prÃ©sence en Russie grÃ¢ce au Projet " Pharmpolis " - Signature au SÃ©minaire intergouvernemental

Sanofi-Aventis To Participate In Russian Project FOXBusiness.com

Sanofi Aventis : Sanofi-aventis confirms its... Investegate

all 4 news articles >> Add Comment

Cardio Drug Micardis Wins EU Nod

Pharmaceutical Technology - 7 Hours ago

The EU has granted approval for Boehringer Ingelheim's Micardis (telmisartan) to prevent morbidity in patients with cardiovascular disease, a leading cause of deaths in Europe. The treatment is the first

Add Comment

Powerful New Hay Fever Drug Available in EU

Pharmaceutical Technology - 7 Hours ago

Stallergenes has been granted approval in Europe to market Oralair, a powerful new immunotherapy tablet for patients with severe rhinoconjunctivitis caused by grass pollens. The treatment, which was first

Add Comment

FDA targets illegal pharma websites

Pharmaceutical Technology - 10 Hours ago

Pharmaceutical Technology Europe The FDA has issued 22 Warning Letters to website operators as part of its International Internet Week of Action, a week-long international effort aimed at curbing illegal

Add Comment

Largest ever study of an antimalarial drug launched

Pharmaceutical Technology - 10 Hours ago

Pharmaceutical Technology Europe An agreement between sanofi-aventis and the Medicines for Malaria Venture (MMV) has lead to the initiation of the largest safety and efficacy study of an antimalarial

Add Comment

Molecules identified from herbs can be potential drugs to treat Parkinson's disease:

PharmaBiz - 10 Hours ago

Researches conducted on certain ayurvedic herbs have provided hope in identifying a set of anti-parkinsonian molecules that might help to design novel drugs for arresting the progression of Parkinson's

Molecules identified from herbs can be potential drugs to treat Parkinoson's disease: PharmaBiz

all 1 news articles >> Add Comment

Novartis to terminate research collaboration agreement with Idera Pharma

PharmaBiz - 15 Hours ago

Idera Pharmaceuticals, Inc, announced that Novartis will terminate its research collaboration agreement with the company, effective as of February 21, 2010. 'We appreciate the commitment Novartis scientists

IDRA: Novartis Terminates R&D Collaboration Agreement Individual.com

Novartis to terminate its research collaboration agreement with Idera Pharmaceuticals News-Medical.Net

all 2 news articles >> Add Comment

GlaxoSmithKline executive becomes president of Chemical Industries Association

Manufacturing Chemist - 16 Hours ago

John Saul, senior vice president of primary manufacturing and engineering for GlaxoSmithKline, has been elected president of the London, UK-based . Saul, who has led the manufacture and supply of active

Add Comment

Lundbeck initiates clinical phase II trials with Lu AE58054 in Alzheimer's disease

Therapeutics Daily - 5 Hours ago

- Denmark-based pharmaceutical company Lundbeck A/S (CPH: LUN) today announced the initiation of a multi-centre, placebo-controlled, fixed-dose study of Lu AE58054 as add-on to donepezil in patients with

H. Lundbeck A/S initiates clinical phase II trials with Lu AE58054 for Alzheimer's Individual.com

Danish Lundbeck starts phase II trial with Lu AE58054 in Alzheimer's ADP News

all 3 news articles >> Add Comment

S. Korea unlikely to buy problematic H1N1 vaccine from GSK

Individual.com - 4 Hours ago

South Korea will likely not order a vaccine against the Influenza A (H1N1) virus made by GlaxoSmithKline Plc. (GSK) after the product seemed to have caused a series of severe allergic reactions in Canada,

S. Korea unlikely to buy H1N1 vaccine from GSK Balita.org

S. Korea unlikely to buy H1N1 vaccine from GSK - Zibb.com Zibb

all 3 news articles >> Add Comment

American Lung Association Welcomes Proposed Sulfur Dioxide Health Standard

Medical News Today - 10 Hours ago

Statement of Charles D. Connor, American Lung Association President and CEO The U.S. Environmental Protection Agency (EPA) proposed new limits on the toxic air pollutant sulfur dioxide in the outdoor

Medical News: American Dental Association Petitions FDA To Classify, Regulate Tooth-Whitening BioFind

Medical News: American Lung Association Welcomes Proposed Sulfur Dioxide Health BioFind

all 2 news articles >> Add Comment

Comprehensive review on pain management pharmaceuticals market

News-Medical.Net - 7 Hours ago

Research and Markets: Pain Management - Global Trends: Availability of Generic Drugs, Individual.com

Report on pain management pharmaceuticals market News-Medical.Net

all 2 news articles >> Add Comment

AIDS patients in Tennessee on waiting list for drugs, services

Individual.com - 4 Hours ago

(The Commercial Appeal - McClatchy-Tribune Information Services via COMTEX) -- With rising unemployment among people infected with HIV, a growing number of uninsured and the increasing cost of antiretroviral

AIDS patients in Tennessee on waiting list for drugs, services [The Commercial Appeal, Therapeutics Daily

all 1 news articles >> Add Comment



	Already a member? Sign in


	Email Address:
	Password:


Forget your password?

Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms of Use | Privacy Policy | Need Help? | Site Map